Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (460)
|
Core Tip (532)
|
Full Article (HTML) (2018)
|
Full Article (PDF)-378K (147)
|
Full Article with Cover (PDF)-633K (135)
|
Full Article (XML)-71K (92)
|
Audio-3309K (53)
|
Peer-Review Report-245K (83)
|
Answering Reviewers-157K (91)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (4633)
|
Similar Articles (160)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches
World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (630)
|
Core Tip (524)
|
Full Article (HTML) (10891)
|
Figures (1-1) (506)
|
Tables (1-3) (483)
|
Full Article (PDF)-4025K (523)
|
Full Article with Cover (PDF)-4275K (241)
|
Full Article (XML)-507K (104)
|
Audio-1047K (33)
|
Peer-Review Report-271K (114)
|
Answering Reviewers-120K (125)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (21)
|
Total Visits (16497)
|
Similar Articles (333)
|
Timeline of Article Publication (14)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (424)
|
Core Tip (456)
|
Full Article (HTML) (2407)
|
Figures (1-1) (381)
|
Full Article (PDF)-1122K (147)
|
Full Article with Cover (PDF)-1376K (143)
|
Full Article (XML)-113K (92)
|
Audio-412K (19)
|
Peer-Review Report-223K (89)
|
Answering Reviewers-109K (76)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6189)
|
Similar Articles (1875)
|
Timeline of Article Publication (10)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (454)
|
Core Tip (511)
|
Full Article (HTML) (2033)
|
Figures (1-1) (363)
|
Tables (1-6) (359)
|
Full Article (PDF)-876K (133)
|
Full Article with Cover (PDF)-1130K (161)
|
Full Article (XML)-191K (103)
|
Audio-454K (28)
|
Peer-Review Report-229K (85)
|
Answering Reviewers-124K (72)
|
Supplementary Material-657K (89)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6553)
|
Similar Articles (82)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms
World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (488)
|
Core Tip (530)
|
Full Article (HTML) (1823)
|
Figures (1-4) (382)
|
Tables (1-3) (381)
|
Full Article (PDF)-8140K (218)
|
Full Article with Cover (PDF)-8392K (144)
|
Full Article (XML)-121K (93)
|
Audio-885K (43)
|
Peer-Review Report-197K (102)
|
Answering Reviewers-155K (114)
|
Supplementary Material-123K (87)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7251)
|
Similar Articles (19)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (469)
|
Core Tip (596)
|
Full Article (HTML) (1772)
|
Figures (1-2) (405)
|
Tables (1-3) (375)
|
Full Article (PDF)-3168K (197)
|
Full Article with Cover (PDF)-3422K (163)
|
Full Article (XML)-97K (94)
|
Audio-586K (51)
|
Peer-Review Report-221K (118)
|
Answering Reviewers-311K (86)
|
Supplementary Material-128K (98)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (6360)
|
Similar Articles (3)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA
World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (448)
|
Core Tip (488)
|
Full Article (HTML) (1447)
|
Figures (1-6) (366)
|
Full Article (PDF)-10367K (154)
|
Full Article with Cover (PDF)-10622K (153)
|
Full Article (XML)-108K (92)
|
Audio-200K (12)
|
Peer-Review Report-203K (89)
|
Answering Reviewers-316K (126)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (4478)
|
Similar Articles (1275)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway
World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (451)
|
Core Tip (451)
|
Full Article (HTML) (1983)
|
Figures (1-8) (439)
|
Full Article (PDF)-42475K (189)
|
Full Article with Cover (PDF)-42729K (174)
|
Full Article (XML)-113K (97)
|
Audio-352K (21)
|
Peer-Review Report-309K (78)
|
Answering Reviewers-116K (80)
|
Supplementary Material-190K (89)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (5453)
|
Similar Articles (144)
|
Timeline of Article Publication (12)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption
World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (442)
|
Core Tip (499)
|
Full Article (HTML) (1882)
|
Figures (1-6) (368)
|
Tables (1-1) (405)
|
Full Article (PDF)-10815K (178)
|
Full Article with Cover (PDF)-11065K (158)
|
Full Article (XML)-143K (89)
|
Audio-400K (38)
|
Peer-Review Report-253K (81)
|
Answering Reviewers-98K (85)
|
Supplementary Material-270K (93)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (7020)
|
Similar Articles (19)
|
Timeline of Article Publication (5)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells
World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (481)
|
Core Tip (510)
|
Full Article (HTML) (1835)
|
Figures (1-7) (426)
|
Full Article (PDF)-9623K (183)
|
Full Article with Cover (PDF)-9876K (144)
|
Full Article (XML)-121K (102)
|
Audio-824K (19)
|
Peer-Review Report-275K (98)
|
Answering Reviewers-363K (108)
|
Supplementary Material-48K (86)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5440)
|
Similar Articles (1850)
|
Timeline of Article Publication (10)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (434)
|
Core Tip (478)
|
Full Article (HTML) (1028)
|
Figures (1-1) (390)
|
Tables (1-2) (402)
|
Full Article (PDF)-471K (109)
|
Full Article with Cover (PDF)-728K (85)
|
Full Article (XML)-61K (97)
|
Audio-512K (27)
|
Peer-Review Report-257K (78)
|
Answering Reviewers-156K (83)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4036)
|
Similar Articles (25)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (526)
|
Core Tip (576)
|
Full Article (HTML) (1899)
|
Tables (1-1) (475)
|
Full Article (PDF)-370K (147)
|
Full Article with Cover (PDF)-625K (159)
|
Full Article (XML)-56K (95)
|
Audio-2970K (19)
|
Peer-Review Report-217K (86)
|
Answering Reviewers-149K (87)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4902)
|
Similar Articles (176)
|
Timeline of Article Publication (3)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (535)
|
Core Tip (498)
|
Full Article (HTML) (4055)
|
Figures (1-1) (392)
|
Full Article (PDF)-1500K (196)
|
Full Article with Cover (PDF)-1754K (154)
|
Full Article (XML)-97K (90)
|
Audio-476K (26)
|
Peer-Review Report-468K (83)
|
Answering Reviewers-1818K (102)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (7223)
|
Similar Articles (306)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed
World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (433)
|
Core Tip (477)
|
Full Article (HTML) (1988)
|
Figures (1-1) (350)
|
Tables (1-1) (401)
|
Full Article (PDF)-578K (140)
|
Full Article with Cover (PDF)-834K (181)
|
Full Article (XML)-91K (85)
|
Audio-833K (26)
|
Peer-Review Report-243K (85)
|
Answering Reviewers-100K (87)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5283)
|
Similar Articles (1850)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (473)
|
Core Tip (528)
|
Full Article (HTML) (4632)
|
Full Article (PDF)-406K (345)
|
Full Article with Cover (PDF)-661K (184)
|
Full Article (XML)-95K (102)
|
Audio-989K (45)
|
Peer-Review Report-215K (75)
|
Answering Reviewers-118K (85)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (7494)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Authors Evaluation (4)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (487)
|
Core Tip (418)
|
Full Article (HTML) (1365)
|
Tables (1-1) (367)
|
Full Article (PDF)-366K (138)
|
Full Article with Cover (PDF)-621K (158)
|
Full Article (XML)-45K (88)
|
Audio-1658K (24)
|
Peer-Review Report-175K (70)
|
Answering Reviewers-38K (74)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4269)
|
Similar Articles (1907)
|
Timeline of Article Publication (4)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
